[Federal Register Volume 60, Number 236 (Friday, December 8, 1995)]
[Notices]
[Pages 63056-63057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-29961]



=======================================================================
-----------------------------------------------------------------------

[[Page 63057]]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 10, 1995, and published in the Federal 
Register on August 17, 1995, (60 FR 42905), Dupont Pharmaceuticals, The 
Dupont Merck Pharmaceutical Company, 1000 Stewart Avenue, Garden City, 
New York 11530, made application to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Oxycodone (9143)...........................  II                         
Hydrocodone (9193).........................  II                         
Oxymorphone (9652).........................  II                         
------------------------------------------------------------------------

    No comments or objections have been received. DEA has determined 
that the registration of Dupont Pharmaceuticals to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. Therefore, pursuant to Section 303 of the Comprehensive Drug 
Abuse Prevention and Control Act of 1970 and Title 21, Code of Federal 
Regulations, Section 1301.54(e), the Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacturer of 
the basic classes of controlled substances listed above is granted.

    Dated: November 29, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
[FR Doc. 95-29961 Filed 12-7-95; 8:45 am]
BILLING CODE 4410-09-M